Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Fuji
Covington
QuintilesIMS
Julphar
Chubb
Dow
Chinese Patent Office

Generated: July 17, 2018

DrugPatentWatch Database Preview

Nesiritide recombinant - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for nesiritide recombinant and what is the scope of nesiritide recombinant patent protection?

Nesiritide recombinant
is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nesiritide recombinant. One supplier is listed for this compound.
Pharmacology for nesiritide recombinant

US Patents and Regulatory Information for nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Julphar
Cipla
US Department of Justice
Healthtrust
US Army
Mallinckrodt
McKesson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.